Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

 Stembancc

 



The University of Oxford is the academic lead institution for StemBANCC. This 5-year research programme involves academic and industry partners across 10 countries. Its objective is to develop human-induced pluripotent stem cells as a platform for drug discovery.

This ambitious project brings together internationally renowned scientists and clinicians to study and develop new therapies for 8 major diseases of our time: Alzheimer’s, Parkinson’s, Autism, Schizophrenia, Bipolar, Migraine, Pain and Diabetes.

StemBANCC in Oxford is a grouping of 8 departments and the world-leading MRC FGU and FMRIB. The project began in 2012, with the HeLEX team taking responsibility for developing the internal ethics and governance frameworks.

StemBANCC is a world-class research programme developing an unparalleled resource of induced pluripotent stem cells from patients with well characterized disorders. It aims to overcome current bottlenecks in stem cell re-programming and differentiation; identify molecular and cellular phenotypes of disease in stem cell models; and translate findings into novel drug screening efficacy and toxicity assays.

You can read more about StemBANCC on the project website for Oxford and the main StemBANCC website.